Administration of vitamin K to newborns: Implications and recommendations

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 3, 1996, Pages 347-349

  McMillan, Douglas D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN K GROUP;

CHILDHOOD CANCER; EDITORIAL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; VITAMIN K DEFICIENCY; CHILD; NEOPLASM; NOTE;

ADMINISTRATION, ORAL; CHILD; HEMORRHAGIC DISEASE OF NEWBORN; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; NEOPLASMS; VITAMIN K;

EID: 0029665278     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Fetus and Newborn Committee, Canadian Paediatric Society: The use vitamin K in the perinatal period. Can Med Assoc J 1988; 139: 127-130
2. Vitamin K Ad Hoc Task Force, American Academy of Pediatrics: Controversies concerning vitamin K and the newborn. Pediatrics 1993; 91: 1001-1003
3. Golding J, Paterson M, Kinlen LJ: Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990; 62: 304-308
4. Golding J, Greenwood R, Birmingham K et al: Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992, 305: 341-346
5. Von Kries R: Vitamin K prophylaxis - A useful public health measure? [review] Paediatr Perinat Epidemiol 1992; 6: 7-13
6. Taddio A, Goldback M, Ipp M et al. Effect of neonatal circumcision on pain responses during vaccination in boys. Lancet 1995; 345: 291-292
7. Lane PA, Hathaway WE: Medical progress: vitamin K in infancy. J Pediatr 1985; 106: 351-359
8. Allen AC: The use of vitamin K in the perinatal period. [letter] Can Med Assoc J 1989; 140: 13-14
9. Ekelund H: Late hemorrhagic disease in Sweden 1987-89. Acta Paediatr Scand 1991; 80: 966-968
10. National Health and Medical Research Council, the Australian College of Paediatrics and the Royal Australian College of Obstetricians and Gynaecologists: Joint statement and interim recommendations on vitamin K prophylaxis for hemorrhagic disease in infancy. J Paediatr Child Health 1993, 29: 182
11. Von Kries R, Kreppel S, Becker A et al: PIVKA-II levels after prophylactic vitamin K. Arch Dis Child 1987; 62: 938-940
12. Hathaway WE, Isarangkura PB, Mahasandana C et al: Comparison of oral and parenteral vitamin K prophylaxis for prevention of late, hemorrhagic disease of the newborn J Pediatr 1991; 119: 461-464
13. Schubiger G, Tönz O, Grüter J et al: Vitamin K concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone. J Pediatr Gsstroenterol Nutr 1993; 16: 435-439
14. Loughnan PM, McDougail PN: Epidemiology of late onset nemorrhagic disease: a pooled data analysis. J Paediatr Child Health 1993; 29: 177-181
15. Von Kries R, Shearer MJ, Göbel U: Vitamin K in infancy. Eur J Pediatr 1988; 147: 106-112
16. Von Kries R, Göbel U: Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy. Acta Paediatr 1992; 81: 655-657
17. Croucher C, Azzopardi D: Compliance with recommendations for giving vitamin K to newborn infants. BMJ 1994; 308: 894-895